Timothy Wilson, PhD

University of North Carolina Chapel Hill
Chapel Hill, United States

Disclosure information not submitted.

Presentation(s):

• SAT-289 - Development of Thienopyrimidine-Based Selective Estrogen Receptor Degraders for Breast Cancer

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT